Amgen results beat estimates, lung cancer trial planned - Reuters

Amgen results beat estimates, lung cancer trial planned  Reuters

Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped ...